secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicus Pharma Ltd. (MDCX)
CIK:        0001997296
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001062993-25-017219
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medicus Pharma enters $5.1M warrant inducement; issues new warrants for 4M shares
--------------------------------------------------------------------------------

- Gross proceeds ~$5.1M from exercise of 2,680,000 existing warrants at amended price of $1.92/share.
- Issued new unregistered Series C/D warrants to purchase 4,020,000 common shares at $2.00, expiring June 5, 2031.
- Company agreed to file resale registration statement for new warrant shares within 60 days of agreement.
- Also reported SEPA sales of 680,893 common shares for ~$1.5M from Oct 28 to Dec 4, 2025.
- Maxim Group LLC acted as exclusive financial advisor; 6.0% cash fee on gross proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325017219/0001062993-25-017219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325017219/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-25-017219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer